New Market Report: IV Diagnostics, Inc. - Product Pipeline Analysis, 2013 Update
IV Diagnostics, Inc. (IV Diagnostics) is a biomedical diagnostic service provider. The company conducts molecular diagnostic tests for circulating tumor cells and other blood borne diseases. It develops, tests and markets diagnostic tools that monitor and measure cancer tumor cells. The company's IVDxTx platform technology, allows physicians to perform real-time diagnosis of the patient's circulating tumor cells (CTCs) without collecting blood. Its IVD CTC tests diagnose cancer, monitor effectiveness of ongoing treatment; and predict disease recurrence after treatment. The company...
View full press release